莱帝土地星 LSTR 深沪

已收盘 02-06 16:00:00 美东时间

162.08

+0.690

+0.43%

华盛通

立即下载

最高164.05
今开160.09
成交量 50.12万股
最低 160.09
昨收 161.39
总市值 55.20亿
52周最高 164.05
市盈率 ^静 48.93
换手率 1.47%
52周最低 116.92
委比 90.61%
总股本 3405.87万
历史最高 199.02
量比 1.00
振幅 2.45%
历史最低 10.545
每手 1
风险率 10.99%

个股概要

财务分析

公司资料

分红派息

分时图
日k
周k
月k

相关新闻

财报速睇 | 莱帝土地星 2025财年Q4营收11.74亿美元，同比下降2.9%；归母净利润0.24亿美元，同比下滑48.2%

华盛资讯1月29日讯，莱帝土地星公布2025财年Q4业绩，公司Q4营收11.74亿美元，同比下降2.9%，归母净利润0.24亿美元，同比下滑48.2%。

01-29 15:51
A Look Ahead: Landstar System's Earnings Forecast

Landstar System (NASDAQ:LSTR) is preparing to release its quarterly earnings on...

01-28 03:02
Landstar System Expects Q4 2025 Revenue Of $1.174B; Expects Q4 2025 EPS Of $0.70; Says Insurance And Claims Costs Of $56M Had Significant Impact On Anticipated Q4 Results

Landstar System, Inc. (NASDAQ:LSTR) ("Landstar" or the "Company") today reported preliminary, unaudited financial results for the 2025 fourth quarter (the "Preliminary Q4 2025 Results").The Company will release its full

01-22 06:00
美股大行评级 | 阿斯麦、美光科技、SanDisk获大行上调目标价；美国银行、富国银行绩后遭多家机构下调目标价

今日重点评级关注：Benchmark：维持TNL Mediagene"投机性买入"评级，目标价从3.5美元升至14美元；康托·菲茨杰拉德：维持Eupraxia Pharmaceuticals"超配"评级，目标价从11美元升至19美元

01-16 10:04
美股大行评级 | 英特尔、美光科技、SanDisk等获大行上调目标价；纽约梅隆银行获5家大行上调目标价

今日重点评级关注：HC Wainwright & Co.：维持Rezolve AI"买入"评级，目标价从10美元升至12美元；HC Wainwright & Co.：维持Largo"买入"评级，目标价从2.9美元升至3.1美元

01-15 16:10
美股大行评级 | 高盛上调谷歌目标价从330美元升至375美元；5家大行集体上调Five Below目标价最高至255美元

今日重点评级关注：HC Wainwright & Co.：维持NioCorp Developments"买入"评级，目标价从9.5美元升至11.25美元；摩根士丹利：维持Chewy"超配"评级，目标价从48美元升至51美元

01-14 11:25
Evercore ISI Group Maintains In-Line on Landstar System, Raises Price Target to $151

Evercore ISI Group analyst Jonathan Chappell maintains Landstar System (NASDAQ:LSTR) with a In-Line and raises the price target from $125 to $151.

01-13 22:46
美股大行评级 | Medline获14家大行首予评级，最高目标价52美元；富国银行上调GOOGL目标价从268美元升至350美元

今日重点评级关注：HC Wainwright & Co.：维持Enlivex Therapeutics"买入"评级，目标价从7美元升至13美元；BTIG：维持Oruka Therapeutics"买入"评级，目标价从63美元升至73美元

01-13 10:18
美股大行评级 | 瑞穗上调英伟达、谷歌、美光科技、SanDisk多家科技股目标价；中金首予诺和诺德"跑赢大市"评级，目标价73.5美元

今日重点评级关注：Needham：维持Cartesian Therapeutics"买入"评级，目标价从40美元升至42美元；Piper Sandler：维持Acrivon Therapeutics"超配"评级，目标价从6美元升至8美元

01-12 14:09
美股大行评级 | 潜在涨幅197.4%！奥麦罗制药获HC Wainwright升目标价至40美元，维持"买入"评级

今日重点评级关注：HC Wainwright & Co.：维持奥麦罗制药"买入"评级，目标价从20美元升至40美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从26美元升至27美元

01-09 20:22

派息除权日	每股总股息	派息日期
2026-02-18	0.40	2026-03-11
2026-01-06	2.00	2026-01-21
2025-11-18	0.40	2025-12-09
2025-08-19	0.40	2025-09-09
2025-06-05	0.40	2025-06-24
2025-02-18	0.36	2025-03-11
2025-01-07	2.00	2025-01-21
2024-11-19	0.36	2024-12-10
2024-08-20	0.36	2024-09-10
2024-05-07	0.33	2024-05-24
2024-02-09	0.33	2024-03-08
2024-01-02	2.00	2024-01-19
2023-11-06	0.33	2023-12-01
2023-08-09	0.33	2023-08-25
2023-05-03	0.30	2023-05-26
2023-02-10	0.30	2023-03-10
2023-01-05	2.00	2023-01-20
2022-11-07	0.30	2022-12-02
2022-08-05	0.30	2022-08-26
2022-05-04	0.25	2022-05-27
2022-02-11	0.25	2022-03-11
2022-01-06	2.00	2022-01-21
2021-11-08	0.25	2021-12-03
2021-08-06	0.25	2021-08-27
2021-05-05	0.21	2021-05-28
2021-02-11	0.21	2021-03-12
2021-01-07	2.00	2021-01-22
2020-11-09	0.21	2020-12-04
2020-08-07	0.21	2020-08-28
2020-05-06	0.19	2020-05-29
2020-02-13	0.19	2020-03-13
2020-01-09	2.00	2020-01-24
2019-11-08	0.19	2019-12-06
2019-08-09	0.19	2019-08-30
2019-05-08	0.17	2019-05-31
2019-02-14	0.17	2019-03-15
2018-11-09	0.17	2018-12-07
2018-08-10	0.17	2018-08-31
2018-05-09	0.15	2018-06-01
2018-02-15	0.15	2018-03-16
2018-01-11	1.50	2018-01-26
2017-11-13	0.10	2017-12-08
2017-08-10	0.10	2017-09-01
2017-05-09	0.09	2017-06-02
2017-02-15	0.09	2017-03-17
2016-11-04	0.09	2016-12-02
2016-08-04	0.09	2016-08-26
2016-05-03	0.08	2016-05-27
2016-02-10	0.08	2016-03-11
2015-11-06	0.08	2015-12-04
2015-08-06	0.08	2015-08-28
2015-05-05	0.07	2015-05-29
2015-02-11	0.07	2015-03-13
2015-01-08	1.00	2015-01-26
2014-11-06	0.07	2014-12-05
2014-08-07	0.07	2014-08-29
2014-05-06	0.06	2014-05-30
2014-02-13	0.06	2014-03-14
2013-12-24	0.35	2014-01-16
2012-12-13	0.50	2012-12-27
2012-11-08	0.06	2012-12-07
2012-08-09	0.06	2012-08-31
2012-05-08	0.05	2012-06-01
2012-02-15	0.05	2012-03-16
2011-11-04	0.05	2011-12-02
2011-08-04	0.05	2011-08-26
2011-05-03	0.05	2011-05-27
2011-02-10	0.05	2011-03-11
2010-10-28	0.05	2010-11-26
2010-08-05	0.05	2010-08-27
2010-05-04	0.05	2010-05-28
2010-02-03	0.05	2010-02-26
2009-10-29	0.05	2009-11-27
2009-08-06	0.05	2009-08-28
2009-05-05	0.04	2009-05-29
2009-02-04	0.04	2009-02-27
2008-10-30	0.04	2008-11-28
2008-08-07	0.04	2008-08-29
2008-05-07	0.04	2008-05-30
2008-02-06	0.04	2008-02-29
2007-11-07	0.04	2007-11-30
2007-08-08	0.04	2007-08-31
2007-05-08	0.03	2007-05-31
2007-02-09	0.03	2007-02-28
2006-11-08	0.03	2006-11-30
2006-08-08	0.03	2006-08-31
2006-05-08	0.03	2006-05-31
2006-02-10	0.03	2006-02-28
2005-11-08	0.03	2005-11-30
2005-08-15	0.03	2005-08-31

公司名称	莱帝土地星
行业分类	物流服务
业务描述	Landstar System, Inc. engages in the provision of transportation management solutions. It operates through the following segments: Transportation Logistics and Insurance. The Transportation Logistics segment offers transportation services including truckload and less-than-truckload transportation, rail intermodal, air and ocean cargo, project cargo, and customs brokerage. The Insurance segment includes risk and claims management services. The company was founded in January 1991 and is headquartered in Jacksonville, FL.

莱帝土地星 LSTR 深 沪

162.08

个股概要

财务分析

公司资料

相关新闻

分红派息

相关新闻

公司简介

莱帝土地星 LSTR 深沪